257 related articles for article (PubMed ID: 25565886)
1. Minimizing second cancer risk following radiotherapy: current perspectives.
Ng J; Shuryak I
Cancer Manag Res; 2015; 7():1-11. PubMed ID: 25565886
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in light ion radiation therapy.
Brahme A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
[TBL] [Abstract][Full Text] [Related]
3. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
4. [Risk of postirradiation induction of cancer of the modern methods of radiotherapy (3D CRT and IMRT) head and neck cancer].
Milecki P; Szyfter K; Skowronek J
Otolaryngol Pol; 2004; 58(5):887-93. PubMed ID: 15732771
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk after radiotherapy for benign diseases.
Mazonakis M; Damilakis J
Phys Med; 2017 Oct; 42():285-291. PubMed ID: 28189418
[TBL] [Abstract][Full Text] [Related]
6. [The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].
Chargari C; Cosset JM
Bull Cancer; 2013 Dec; 100(12):1333-42. PubMed ID: 24257106
[TBL] [Abstract][Full Text] [Related]
7. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
[TBL] [Abstract][Full Text] [Related]
8. Risk of second cancer after ion beam radiotherapy: insights from animal carcinogenesis studies.
Imaoka T; Nishimura M; Daino K; Takabatake M; Moriyama H; Nishimura Y; Morioka T; Shimada Y; Kakinuma S
Int J Radiat Biol; 2019 Oct; 95(10):1431-1440. PubMed ID: 30495977
[No Abstract] [Full Text] [Related]
9. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
[TBL] [Abstract][Full Text] [Related]
10. Models for the risk of secondary cancers from radiation therapy.
Dasu A; Toma-Dasu I
Phys Med; 2017 Oct; 42():232-238. PubMed ID: 28242139
[TBL] [Abstract][Full Text] [Related]
11. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
Teh BS; Paulino A; Butler EB
Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
[TBL] [Abstract][Full Text] [Related]
12. Estimating the excess lifetime risk of radiation induced secondary malignancy (SMN) in pediatric patients treated with craniospinal irradiation (CSI): Conventional radiation therapy versus helical intensity modulated radiation therapy.
Holmes JA; Chera BS; Brenner DJ; Shuryak I; Wilson AK; Lehman-Davis M; Fried DV; Somasundaram V; Lian J; Cullip T; Marks LB
Pract Radiat Oncol; 2017; 7(1):35-41. PubMed ID: 27663930
[TBL] [Abstract][Full Text] [Related]
13. High-tech in radiation oncology: should there be a ceiling?
Bentzen SM
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):320-30. PubMed ID: 14751499
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
15. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
[TBL] [Abstract][Full Text] [Related]
16. The effect of radiation quality on the risks of second malignancies.
Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
[TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
18. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced Non-targeted Effect and Carcinogenesis; Implications in Clinical Radiotherapy.
Yahyapour R; Salajegheh A; Safari A; Amini P; Rezaeyan A; Amraee A; Najafi M
J Biomed Phys Eng; 2018 Dec; 8(4):435-446. PubMed ID: 30568933
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology.
Peitzsch C; Kurth I; Ebert N; Dubrovska A; Baumann M
Int J Radiat Biol; 2019 Jul; 95(7):900-911. PubMed ID: 30897014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
